BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. SPG

Go back to BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
(NASDAQ: BBIO) Delayed: 74.84 -0.57 (0.76%)
Previous Close $75.41    52 Week High $ 
Open $74.98    52 Week Low $ 
Day High $75.37    P/E N/A 
Day Low $74.11    EPS $ 
Volume 1,540,365